Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Batist

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumorsL Panasci, S F Stinson, D Melnychuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.
American Journal of Clinical Oncology|August 1, 1990
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicityE Dmitrovsky, E J Seifter, A F Gazdar, et al.
Lung|October 8, 2005
Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancerS F Dent, A Arnold, D J Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Benefits, issues, and recommendations for personalized medicine in oncology in CanadaC Butts, S Kamel-Reid, G Batist, et al.
Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264A P Venook, M J Egorin, G L Rosner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancerG Batist, G Ramakrishnan, C S Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III studyP M Hoff, R Ansari, G Batist, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumorsL Panasci, S F Stinson, D Melnychuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.
American Journal of Clinical Oncology|August 1, 1990
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicityE Dmitrovsky, E J Seifter, A F Gazdar, et al.
Lung|October 8, 2005
Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancerS F Dent, A Arnold, D J Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Benefits, issues, and recommendations for personalized medicine in oncology in CanadaC Butts, S Kamel-Reid, G Batist, et al.
Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264A P Venook, M J Egorin, G L Rosner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancerG Batist, G Ramakrishnan, C S Rao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III studyP M Hoff, R Ansari, G Batist, et al.
Pageof 12